Skip to main content
. 2021 Apr;10(1):60–68. doi: 10.52547/rbmb.10.1.60

Table 1.

The frequency of different TNM staging system of prostate cancer and the corresponding relationship with family history and smoking.

TNM staging system (n= 40) Frequency (%) Smoking habit Family history
Yes (%) No (%) NA (%) Yes (%) No (%) NA (%
T1N0M0 1 (2.5) 1 (2.5) - - - 1 (2.5) -
T1N1M1 1 (2.5) 1 (2.5) - - 1 (2.5) - -
T2N1M0 19 (47.5) 11 (27.5) 7 (17.5) 1 (2.5) 3 (7.5) 15 (37.5) 1 (2.5)
T2N1M1 4 (10) - 4 (10) - - 4 (10) -
T2N2M1 7 (17.5) 4 (10) 3 (7.5) - 2 (5) 4 (10) 1 (2.5)
T3N1M1 2 (5) - 2 (5) - 2 (5) - -
T4N1M1 1 (2.5) 1 (2.5) - - - 1 (2.5) -
NA 5 (12.5) 2 (5) 1 (2.5) 2 (5) 1 (2.5) 3 (7.5) 1 (2.5)

T0: In these cases, there is no evidence of tumor in the prostate tissue.

T1: The tumor cannot be detected during a digital rectal exam (DRE) and cannot be seen using imaging tests.

T2: The tumor is large enough to be detected during DRE.

T3: The tumor has grown through the prostate on 1 side and into the tissue just outside the prostate.

T4: The tumor is fixed, or it is growing into adjacent structures other than the seminal vesicles.

N0: Prostate cancer has not yet extended to the regional lymph nodes.

N1: In these cases, the cancer has extended to the pelvic lymph nodes.

M0: Prostate cancer has not metastasized.

M1: Metastasis to distant tissues has occurred.

* TNM staging system was not applicable on five samples.